Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, SoftMedX Healthcare's Enterprise Value is HK$34.75 Mil.
SoftMedX Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was HK$18.93 Mil. Therefore, SoftMedX Healthcare's EV-to-FCF for today is 1.84.
The historical rank and industry rank for SoftMedX Healthcare's EV-to-FCF or its related term are showing as below:
HKSE:00648'
s EV-to-FCF Range Over the Past 10 Years
Min: -115.47 Med: -16.35 Max: 115.56
Current: 1.84
During the past 13 years, the highest EV-to-FCF of SoftMedX Healthcare was 115.56. The lowest was -115.47. And the median was -16.35.
HKSE:00648's EV-to-FCF is ranked better than 94.92% of 413
companies
in the Healthcare Providers & Services industry
Industry Median: 18.55
vs HKSE:00648: 1.84
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SoftMedX Healthcare's PE Ratio (TTM) for today is calculated as:
SoftMedX Healthcare's share price for today is HK$0.56.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SoftMedX Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was HK$0.078.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SoftMedX Healthcare EV-to-FCF Related Terms
SoftMedX Healthcare EV-to-FCF Historical Data
* Premium members only.
The historical data trend for SoftMedX Healthcare's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, SoftMedX Healthcare's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SoftMedX Healthcare EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SoftMedX Healthcare's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where SoftMedX Healthcare's EV-to-FCF falls into.
SoftMedX Healthcare's current Enterprise Value is HK$34.75 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SoftMedX Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was HK$18.93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SoftMedX Healthcare (HKSE:00648) has a EV-to-FCF of 1.84 as of Aug. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on SoftMedX Healthcare and its competitors. According to the industry distribution chart, SoftMedX Healthcare ranks #21 out of 413 companies in the Healthcare Providers & Services industry, placing it in the top 5.1%.
Is SoftMedX Healthcare's EV-to-FCF too high?
SoftMedX Healthcare's current EV-to-FCF is 1.84. The Healthcare Providers & Services industry median EV-to-FCF is 18.55. SoftMedX Healthcare's value of 1.84 is 90.1% below this industry median. Based on the distribution chart, SoftMedX Healthcare ranks #21 out of 413 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, SoftMedX Healthcare has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SoftMedX Healthcare's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, SoftMedX Healthcare ranks #21 out of 413 companies for EV-to-FCF. This places SoftMedX Healthcare in the top 5% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 18.55. SoftMedX Healthcare's value of 1.84 is 90.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.55, based on 413 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SoftMedX Healthcare's current EV-to-FCF of 1.84 is 90.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on SoftMedX Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SoftMedX Healthcare's current EV-to-FCF is 1.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SoftMedX Healthcare stock overvalued right now?
Based on GuruFocus' analysis, SoftMedX Healthcare (HKSE:00648) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.52, compared to a current price of HK$0.56 — trading 77.8% below its estimated fair value. The current EV-to-FCF is 1.84 and 90.1% below the Healthcare Providers & Services industry median of 18.55. SoftMedX Healthcare's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For SoftMedX Healthcare (HKSE:00648), the current EV-to-FCF is 1.84 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SoftMedX Healthcare (HKSE:00648) Overvalued in 2026?
Based on GuruFocus' analysis, SoftMedX Healthcare stock appears to be undervalued.
The current stock price of HK$0.56 is trading 77.8% below its estimated GF Value™ of HK$2.52.
GuruFocus considers SoftMedX Healthcare to be Possible Value Trap.
Key valuation signals for HKSE:00648:
EV-to-FCF: 1.84
GF Value™: HK$2.52 vs. price of HK$0.56 (77.8% below fair value)
Industry Position: 90.1% below the Healthcare Providers & Services median (#21 of 413)
No single metric tells the full story. See the HKSE:00648 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SoftMedX Healthcare Ltd is principally engaged in the distribution of medical and healthcare equipment and products. The Group has one reportable operating segment: medical and well-being business, for the Distribution of medical and healthcare equipment and products.
54GF Score
Get the complete analysis for HKSE:00648
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00648 has been successfully added to your 
